MIR-27a regulates the TGF-β signaling pathway by targeting SMAD2 and SMAD4 in lung cancer

Molecular Carcinogenesis

Volumn 56, Issue 8, 2017, Pages 1992-1998

  Chae, Dong Kyu ^a,b   Ban, Eunmi ^a   Yoo, Young Sook ^a   Kim, Eunice EunKyeong ^a   Baik, Ja Hyun ^b   Song, Eun Joo ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea University   (South Korea)

Author keywords

lung cancer; miR 27a; SMAD2; SMAD4; TGF

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 27A; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; MIRN27 MICRORNA, HUMAN; SMAD2 PROTEIN, HUMAN; SMAD4 PROTEIN, HUMAN;

ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DATA BASE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CANCER CELL LINE; ONCOGENE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; CELL CYCLE; GENE EXPRESSION REGULATION; GENETICS; LUNG; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 85017505665     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22655     Document Type: Article

References (23)

1. Waite KA, Eng C. From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family. Nat Rev Genet. 2003; 4:763–773.
2. Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer. 2010; 10:415–424.
3. Zarzynska JM. Two faces of TGF-beta1 in breast cancer. Mediators Inflamm. 2014; 2014:141747.
4. Malkoski SP, Wang XJ. Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancer. FEBS Lett. 2012; 586:1984–1992.
5. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215–233.
6. Tian Y, Fu S, Qiu GB, et al. MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma. BMC Cancer. 2014; 14:678.
7. Towers CG, Guarnieri AL, Micalizzi DS, et al. The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p. Nat Commun. 2015; 6:10077.
8. Chhabra R, Dubey R, Saini N. Cooperative and individualistic functions of the microRNAs in the miR-23a ∼ 27a ∼ 24-2 cluster and its implication in human diseases. Mol Cancer. 2010; 9:232.
9. Zhu L, Wang Z, Fan Q, Wang R, Sun Y. MicroRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS. Oncol Rep. 2014; 31:280–286.
10. Li Y, Li J, Sun X, et al. MicroRNA-27a functions as a tumor suppressor in renal cell carcinoma by targeting epidermal growth factor receptor. Oncol Lett. 2016; 11:4217–4223.
11. Wan X, Huang W, Yang S, et al. Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression. Int J Biochem Cell Biol. 2016; 79:249–260.
12. Massague J. G1 cell-cycle control and cancer. Nature. 2004; 432:298–306.
13. Cui H, Banerjee S, Xie N, et al. MicroRNA-27a-3p is a negative regulator of lung fibrosis by targeting myofibroblast differentiation. Am J Respir Cell Mol Biol. 2016; 54:843–852.
14. Bao Y, Chen Z, Guo Y, et al. Tumor suppressor microRNA-27a in colorectal carcinogenesis and progression by targeting SGPP1 and Smad2. PLoS ONE. 2014; 9:105991.
15. Liu T, Tang H, Lang Y, Liu M, Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett. 2009; 273:233–242.
16. Ma Y, Yu S, Zhao W, Lu Z, Chen J. MiR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett. 2010; 298:150–158.
17. Wang Q, Li DC, Li ZF, et al. Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen. Oncogene. 2011; 30:3875–3886.
18. Samanta D, Datta PK. Alterations in the Smad pathway in human cancers. Front Biosci. 2012; 17:1281–1293.
19. Anumanthan G, Halder SK, Osada H, et al. Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells. Br J Cancer. 2005; 93:1157–1167.
20. Yanagisawa K, Uchida K, Nagatake M, et al. Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers. Oncogene. 2000; 19:2305–2311.
21. Shugang X, Hongfa Y, Jianpeng L, et al. Prognostic value of SMAD4 in pancreatic cancer: a meta-Analysis. Transl Oncol. 2016; 9:1–7.
22. Yang H, Wang L, Zhao J, et al. TGF-beta-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer. Lung Cancer. 2015; 87:249–257.
23. Zhang JX, Zhai JF, Yang XT, Wang J. MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGFbeta1/Smad2 in human non-small cell lung cancer. Eur Rev Med Pharmac Sci. 2016; 20:3793–3801.